Novo Nordisk A/S Sponsored ADR (0TDD)
LSE
Closed
Oct 7, 2026
Day's Range
37.0952 wk Range
35.09Overview - 0TDD - Novo Nordisk A/S Sponsored ADR
Key Statistics
Valuation
Enterprise Value
40.57B
P/E (Trailing)
‪0.12‬
Price / Book
‪5.07‬
EV / EBITDA
‪1.53‬
Profitability
Profit Margin
‪35.34%‬
Operating Margin
‪42.54%‬
Return on Assets
‪18.72%‬
Return on Equity
‪59.81%‬
Ownership
Shares Outstanding
2.41B
Float
3.17B
Held by Insiders
‪0.0030%‬
Held by Institutions
‪9.90%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪116.39‬
200-Day Avg
‪97.55‬
Dividends
Frequency
Semi-Annual
Market Cap - 0TDD - Novo Nordisk A/S Sponsored ADR
Peers - 0TDD - Novo Nordisk A/S Sponsored ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
Profile Summary - 0TDD - Novo Nordisk A/S Sponsored ADR
About
Novo Nordisk A/S Sponsored ADR is a healthcare company focused on discovering, developing, manufacturing, and marketing pharmaceutical products. The company’s current business is organized around diabetes and obesity care, where it offers treatments and related devices for chronic metabolic conditions, and rare…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
